NIH

Dengue Vaccine Shows 100 % Protection In Small Study; Spurs Phase 3 Trials

By Peter R - Mar 17, 2016 03:03 PM EDT

The vaccine protected volunteers against an mild attenuated form of all four serotypes of dengue virus. Its success in phase 3 clinical trials could boost zika vaccine development.

NIH to Stop Funding Invasive Research Testing on Chimps

By Cheri Cheng - Nov 20, 2015 04:05 PM EST

The U.S. National Institutes of Health (NIH) is ending an era of research testing on chimpanzees.

Fun Stuff

Editor's pick

Real Time Analytics